Vitae Pharmaceuticals Patents – Insights & Stats (Updated 2023)
August 29, 2023
Vitae Pharmaceuticals has a total of 988 patents globally, out of which 460 have been granted. Of these 988 patents, more than 43% patents are active. The United States of America is where Vitae Pharmaceuticals has filed the maximum number of patents, followed by Europe and Japan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Vitae Pharmaceuticals.
Vitae Pharmaceuticals was founded in 2001. The Company offers clinical-stage biopharmaceutical products. The Company develops small molecule compounds that address medical needs such as chronic kidney disease, diabetes, atherosclerosis and alzheimer’s diseases.
Do read about some of the most popular patents of Vitae Pharmaceuticals which have been covered by us in this article and also you can find Vitae Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vitae Pharmaceuticals patent portfolio.
How many patents does the Founder of Vitae Pharmaceuticals have?
The Founder John J. Baldwin has 93 patents.
How many patents does Vitae Pharmaceuticals have?
Vitae Pharmaceuticals has a total of 988 patents globally. These patents belong to 157 unique patent families. Out of 988 patents, 427 patents are active.
How Many Patents did Vitae Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant
Vitae Pharmaceuticals Applications Filed
Vitae Pharmaceuticals Patents Granted
2023
2
11
2022
8
14
2021
9
37
2020
25
29
2019
16
39
2018
54
17
2017
78
44
2016
55
54
2015
89
57
2014
23
53
2013
122
58
How many Vitae Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Vitae Pharmaceuticals File in Different Countries?
Countries in which Vitae Pharmaceuticals Filed Patents
Country
Patents
United States Of America
123
Europe
65
Japan
63
Canada
43
Germany
37
Austria
34
Hong Kong (S.A.R.)
29
Mexico
28
Australia
27
Israel
26
India
25
Brazil
24
Korea (South)
24
Taiwan
22
Argentina
21
Singapore
19
South Africa
19
China
18
Chile
18
New Zealand
15
Philippines
14
Spain
13
Denmark
12
Malaysia
12
Indonesia
11
Peru
11
Uruguay
9
Viet Nam
8
Colombia
8
Tunisia
7
Slovenia
7
Malta
7
Morocco
7
Poland
7
Portugal
7
Norway
7
Croatia
6
Estonia
6
Albania
6
Hungary
6
Ecuador
6
Serbia
5
Italy
5
Slovakia
5
Cyprus
4
Africa
4
Lithuania
4
Russia
4
Georgia
4
Eurasia
3
Montenegro
3
San Marino
3
Gulf Cooperation Council
2
Saudi Arabia
2
Thailand
1
Finland
1
Macao
1
Former Yugoslav Republic of Macedonia
1
Africa
1
Where are Research Centers of Vitae Pharmaceuticals Patents Located?
10 Best Vitae Pharmaceuticals Patents
WO2009017664A1 is the most popular patent in the Vitae Pharmaceuticals portfolio. It has received 128 citations so far from companies like Sanofi, Glaxo Group Limited and Abbott Laboratories.
Below is the list of 10 most cited patents of Vitae Pharmaceuticals:
What Percentage of Vitae Pharmaceuticals US Patent Applications were Granted?
Vitae Pharmaceuticals (Excluding its subsidiaries) has filed 36 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 30 have been granted leading to a grant rate of 88.24%.
Below are the key stats of Vitae Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Vitae Pharmaceuticals?
Law Firm
Total Applications
Success Rate
Mccarter & English
31
86.67%
Cooley
4
100.00%
Allergan
1
100.00%
What are Vitae Pharmaceuticals key innovation segments?
What Technologies are Covered by Vitae Pharmaceuticals?
The chart below distributes patents filed by Vitae Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Vitae Pharmaceuticals thinks it’s important to protect particular technology inventions.
R&D Focus: How has Vitae Pharmaceuticals search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Vitae Pharmaceuticals?
CDGM Glass has a total of 42 patents globally, out of which 89 have been granted. Of these 42 patents, more than 82% patents are active. China is where CDGM Glass has filed the maximum number of patents, followed by Taiwan. Parallelly, China seems to be the main focused R&D
Askey Technology (Jiangsu) has a total of 451 patents globally, out of which 148 have been granted. Of these 451 patents, more than 9% patents are active. China is where Askey Technology (Jiangsu) has filed the maximum number of patents, followed by Taiwan and United States of America. Parallelly, Taiwan
Artin Industrial has a total of 5 patents globally, out of which no patent has been granted. Of these 5 patents, all the patents are dead. The United States of America is where Artin Industrial has filed all their patents followed by Hong Kong (S.A.R.) and Europe (EPO). Parallelly, United
Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
